134 related articles for article (PubMed ID: 22926202)
1. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
De Schutter TM; Behets GJ; Jung S; Neven E; D'Haese PC; Querfeld U
Calcif Tissue Int; 2012 Nov; 91(5):307-15. PubMed ID: 22926202
[TBL] [Abstract][Full Text] [Related]
2. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
Jung S; Querfeld U; Müller D; Rudolph B; Peters H; Krämer S
J Hypertens; 2012 Nov; 30(11):2182-91. PubMed ID: 22902873
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Henley C; Colloton M; Cattley RC; Shatzen E; Towler DA; Lacey D; Martin D
Nephrol Dial Transplant; 2005 Jul; 20(7):1370-7. PubMed ID: 15855208
[TBL] [Abstract][Full Text] [Related]
4. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
[TBL] [Abstract][Full Text] [Related]
7. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
Henley C; Davis J; Miller G; Shatzen E; Cattley R; Li X; Martin D; Yao W; Lane N; Shalhoub V
Eur J Pharmacol; 2009 Aug; 616(1-3):306-13. PubMed ID: 19470383
[TBL] [Abstract][Full Text] [Related]
8. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
[TBL] [Abstract][Full Text] [Related]
9. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
[TBL] [Abstract][Full Text] [Related]
10. PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats.
Phan O; Maillard M; Peregaux C; Mordasini D; Stehle JC; Funk F; Burnier M
J Pharmacol Exp Ther; 2013 Aug; 346(2):281-9. PubMed ID: 23697346
[TBL] [Abstract][Full Text] [Related]
11. Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.
Damment SJ; Shen V
Clin Nephrol; 2005 Feb; 63(2):127-37. PubMed ID: 15730055
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of strontium on bone of chronic renal failure rats.
Schrooten I; Behets GJ; Cabrera WE; Vercauteren SR; Lamberts LV; Verberckmoes SC; Bervoets AJ; Dams G; Goodman WG; De Broe ME; D'Haese PC
Kidney Int; 2003 Mar; 63(3):927-35. PubMed ID: 12631073
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E protection of obesity-enhanced vascular calcification in uremic rats.
Peralta-Ramírez A; Montes de Oca A; Raya AI; Pineda C; López I; Guerrero F; Diez E; Muñoz-Castañeda JR; Martinez J; Almaden Y; Rodríguez M; Aguilera-Tejero E
Am J Physiol Renal Physiol; 2014 Feb; 306(4):F422-9. PubMed ID: 24370590
[TBL] [Abstract][Full Text] [Related]
14. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.
Lopez I; Mendoza FJ; Guerrero F; Almaden Y; Henley C; Aguilera-Tejero E; Rodriguez M
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1376-85. PubMed ID: 19321594
[TBL] [Abstract][Full Text] [Related]
15. 1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.
Lippuner K; Perrelet R; Casez JP; Popp A; Uskokovic MR; Jaeger P
Horm Res; 2004; 61(1):7-16. PubMed ID: 14646396
[TBL] [Abstract][Full Text] [Related]
16. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.
Amann K; Törnig J; Flechtenmacher C; Nabokov A; Mall G; Ritz E
Nephrol Dial Transplant; 1995 Nov; 10(11):2043-8. PubMed ID: 8643165
[TBL] [Abstract][Full Text] [Related]
17. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.
Lopez I; Aguilera-Tejero E; Mendoza FJ; Almaden Y; Perez J; Martin D; Rodriguez M
J Am Soc Nephrol; 2006 Mar; 17(3):795-804. PubMed ID: 16467452
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
[TBL] [Abstract][Full Text] [Related]
19. How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?
Shahapuni I; Mansour J; Harbouche L; Maouad B; Benyahia M; Rahmouni K; Oprisiu R; Bonne JF; Monge M; El Esper N; Presne C; Moriniere P; Choukroun G; Fournier A
Semin Dial; 2005; 18(3):226-38. PubMed ID: 15934970
[TBL] [Abstract][Full Text] [Related]
20. Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia.
Nakagawa K; Pérez EC; Oh J; Santos F; Geldyyev A; Gross ML; Schaefer F; Schmitt CP
Nephrol Dial Transplant; 2008 Sep; 23(9):2761-7. PubMed ID: 18408076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
